Understanding uveitis: The impact of research on visual outcomes
Section snippets
The clinical importance of uveitis
Uveitis is an umbrella term used to describe a wide variety of inflammatory conditions occurring inside the eye. The term literally means inflammation of the uvea (Latin for grape), i.e. the iris, ciliary body and choroid, but adjacent structures such as the retina, optic nerve and sclera may also be involved. Uveitis accounts for 5–20% of legal blindness in both the United States and Europe, and perhaps as much as 25% of blindness in the developing world (Bodaghi et al., 2001, Rothova et al.,
Animal models in uveitis
Taking repeated ocular biopsies from patients is not ethically possible. Hence our understanding of the mechanisms of ocular damage in uveitis have come from using animal models (de Smet and Chan, 2001). Furthermore, histopathologic data derived from ocular samples provides data at only one timepoint, usually late in the course of the disease, whereas experimental models allow analysis during the entire disease process. Several animal species can be used to understand different aspects of the
Clinical, diagnostic and evaluation challenges in uveitis
Although uveitis encompasses a multitude of etiologies and disease phenotypes, its management relies on a set of pivotal factors: correct anatomical classification and etiologic diagnosis, identification of complications, assessment of disease activity, and the presence of any systemic disease associations (Guly and Forrester, 2010). Challenges remain in all of these areas, particularly as traditional biomedical thinking in uveitis care has led to an overemphasis on diagnostic testing. An
Challenges in disease management
Uveitis is a disease of varying phenotypes and visual prognosis: inflammation may be mild, moderate or severe; sight-affecting or sight-threatening complications may already be present at presentation; patients may be very symptomatic, particularly if there is severe anterior chamber involvement, macular edema with visual loss or vitritis with numerous floaters. These factors often drive clinical decision-making, but not all patients with uveitis require treatment. Patients with chronic
Predictors of disease activity
It would be ideal to identify patients who are in a high risk group for visual loss early in their disease process. This would enable a more aggressive approach to therapy to be taken, possibly preventing this loss of vision. It would also be useful to predict which patients are likely to be refractory to commonly used medication, to have more a severe inflammatory process, or to develop complications of uveitis such as glaucoma. Cytokine levels in blood and ocular fluids, intracellular
How can disease management be improved
Classical clinical trials rest on binary outcomes. This approach has endured the test of time and is favored by regulators, but it carries with it important ethical, economic and timing issues. For example, eyes in a control arm are at risk of permanent vision loss unless protocols are set up to include eyes with less severe disease even in the presence of rescue therapy. We group under the term uveitis a number of very different clinical entities whose only common denominator is the presence
References (311)
- et al.
Chemokines and gelatinases in the aqueous humor of patients with active uveitis
Am. J. Ophthalmol.
(2004) - et al.
The importance of visual function in the quality of life of children with uveitis
J. AAPOS
(2010) - et al.
Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study
Ophthalmology
(2001) - et al.
Vitrectomy in the treatment of uveitis
Am. J. Ophthalmol.
(2005) - et al.
Prevalence and genotypes of Toxoplasma gondii in feline faeces (oocysts) and meat from sheep, cattle and pigs in Switzerland
Vet. Parasitol.
(2011) - et al.
Chlorambucil and malignancy
Ophthalmology
(2010) - et al.
International uveitis study group recommendations for the evaluation of intraocular inflammatory disease
Am. J. Ophthalmol.
(1987) - et al.
Characteristics of uveitis presenting for the first time in the elderly
Ophthalmology
(1998) - et al.
Endotoxin-induced uveitis in the rat: observations on altered vascular permeability, clinical findings, and histology
Exp. Eye Res.
(1984) - et al.
Quality of life and health economic assessments of age-related macular degeneration
Surv. Ophthalmol.
(2007)